Skip to main content
. 2023 May 5;10(1):e001440. doi: 10.1136/bmjresp-2022-001440

Table 3.

Mortality and risk analysis in patients with pleural infection cases

Characteristic Pleural Infection
Total patients (N=100) 30-day mortality
N (%)
90-day mortality
N (%)
365-day mortality
N (%)
(A) Mortality among 100 pneumococcal pleural infection cases with different clinical features and RAPID severity scores
Disease characteristics
Pus 59 0 (0) 0 (0) 1 (2)
No pus 41 9 (22) 12 (29) 12 (29)
Loculation present 49 8 (16) 10 (20) 12 (25)
No loculation detected 51 1 (2) 2 (4) 5 (10)
Fibrinolytics used 33 4 (12) 6 (18) 11 (33)
Surgical management* 29 0 (0) 0 (0) 0 (0)
 Loculation present 23 0 (0) 0 (0) 0 (0)
 No loculation 6 0 (0) 0 (0) 0 (0)
No surgical management 71 9 (13) 12 (17) 17 (24)
RAPID risk group
Low 36 1 (3) 1 (3) 3 (8)
Medium 46 2 (4) 3 (7) 4 (9)
High 18 6 (33) 10 (55) 13 (72)
(B) Cox regression analysis for risk factors in patients with pleural infection
Analysis Factor Beta (β) estimate HR 95% CI Р value
30-day mortality RAPID
group
Low
Medium 13.52 12.04 0.23 to 39.87 0.674
High 28.51 19.33 0.55 to 92.33 0.638
Age −0.002 0.998 0.96 to 1.05 0.921
Loculation 1.705 5.502 0.99 to 103 0.111
90-day mortality RAPID
group
Low
Medium 0.573 1.773 0.19 to 38.77 0.642
High 2.709 15.01 1.24 to 40.06 0.049
Age 0.015 1.02 0.97 to 1.07 0.55
Loculation 1.582 4.86 1.27 to 31.87 0.043
365-day mortality RAPID
group
age
Low
Medium 0.573 1.773 0.19 to 38.77 0.642
High 2.709 15.01 1.24 to 40.06 0.049
Age 0.027 1.028 0.99 to 1.07 0.188
Loculation 1.041 2.836 1.04 to 9.00 0.05

RAPID (Renal, Age, Purulence, Infection source, and Dietary factors) score 0–2 represents low risk, 3–4 medium risk and 5–7 high risk.

Proportional hazard assumptions were tested by visual assessment of the Kaplan-Meier survival curve, log(-log) plots and Schoenfeld Residuals (online supplemental data 8).

*Eighteen patients underwent surgery after fibrinolytic usage.